|
ZDHHC23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.629800E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.452360E-02 |
| Stage1-vs-Stage3 |
6.240300E-02 |
| Stage1-vs-Stage4 |
9.647700E-04 |
| Stage2-vs-Stage3 |
1.177490E-03 |
| Stage2-vs-Stage4 |
1.017830E-04 |
| Stage3-vs-Stage4 |
2.765000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.65929961279699E-10 |
| Normal-vs-Asian |
5.60549995309856E-09 |
| Caucasian-vs-AfricanAmerican |
9.235200E-01 |
| Caucasian-vs-Asian |
7.307600E-02 |
| AfricanAmerican-vs-Asian |
2.225800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-15 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.856800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62581059726108E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
7.54973861205599E-12 |
| Normal-vs-Age(81-100Yrs) |
1.417899999967E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.073800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.844000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.570400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.281200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.960800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.407600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.53939999969488E-07 |
| Classical-VS-Follicular |
3.261500E-03 |
| Classical-VS-Other |
1.944810E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.55649999555862E-08 |
| Tall-VS-Other |
5.995600E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.796130E-03 |
| Follicular-VS-Normal |
3.88630000003332E-06 |
| Other-VS-Normal |
8.73609962148691E-10 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.88178419700125E-16 |
| Normal-vs-N1 |
4.54969395491389E-13 |
| N0-vs-N1 |
2.527200E-01 |
|
|
